Corporate Board Profile
Tech Score: 100/100
2 mention(s) identify IRAJ E. KIANI, PH.D. as having software/technology expertise.
Company | Filing Date | Evidence | Reason |
---|---|---|---|
AIM ImmunoTech Inc. | 2015-07-07 | IRAJ E. KIANI, Ph.D. was appointed to the Board of Directors on May 1, 2002. Dr. Kiani is a planning and logistic specialist who is now applying his knowledge and experience to various immunology related activities. He also has experience working with an immunotherapy clinic in California. | Dr. Kiani holds a Ph.D. and has experience in immunotherapy and clinical trials, with a background in planning and logistics and international business, indicating technical expertise adjacent to software and scientific research. |
AIM ImmunoTech Inc. | 2015-08-10 | IRAJ E. KIANI, Ph.D. - Director Qualifications: Leadership Experience – public office in Iran; Industry Experience – Broad international business network and contacts within the field of immunology; Scientific, Legal or Regulatory Experience – experience in field and business of immunotherapy and clinical trial experience; and Finance Experience – over 40 years of international business experience. | Dr. Kiani holds a Ph.D. and has experience in immunotherapy and clinical trials, with over 40 years of international business experience, indicating a technical background that may include scientific and analytical skills relevant to programming. |
Filing Date | Source Excerpt |
---|---|
2015-07-07 | IRAJ E. KIANI, Ph.D. was appointed to the Board of Directors on May 1, 2002. Dr. Kiani is a planning and logistic specialist who is now applying his knowledge and experience to various immunology related activities. He also has experience working with an immunotherapy clinic in California. |
2015-08-10 | IRAJ E. KIANI, Ph.D. - Director Qualifications: Leadership Experience – public office in Iran; Industry Experience – Broad international business network and contacts within the field of immunology; Scientific, Legal or Regulatory Experience – experience in field and business of immunotherapy and clinical trial experience; and Finance Experience – over 40 years of international business experience. |
Data sourced from SEC filings. Last updated: 2025-10-12